Yokozeki H, Fujimoto T, Abe Y, Igarashi M, et al. A phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group study of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis. J Dermatol 2021;48:279-288.
PMID: 33410265